Kirby Institute
Research facility
Location:
Kensington,
Australia (AU)
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies (2025)
Mazigi O, Langley DB, Henry JY, Burnett DL, Sobti M, Walker GJ, Rouet R, et al.
Journal article
Discovery of a monoclonal, high-affinity CD8+ T-cell clone following natural hepatitis C virus infection (2024)
Cai C, Keoshkerian E, Wing K, Samir J, Effenberger M, Schober K, Bull RA, et al.
Journal article
Research, HIV/AIDS, and Turning Waria into a Key Population in Indonesia: An Ethnographic Oral History (2024)
Hegarty B, Thajib TF, Handayani AP, Mallay R, Marischa A
Journal article
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability (2021)
Burnett DL, Jackson KJ, Langley DB, Aggrawal A, Stella AO, Johansen MD, Balachandran H, et al.
Journal article